Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05997875 · ClinicalTrials.gov registry record · NA

Transforming Hemodialysis-Related Vascular Access Education

A NA study of Chronic Kidney Disease and Hemodialysis Vascular Access, sponsored by University of Pennsylvania.

Recruiting
Registry status
NA
Development phase
360
Enrollment target
2
Study locations

NCT05997875 is a NA study of Chronic Kidney Disease and Hemodialysis Vascular Access that is actively recruiting participants, run by University of Pennsylvania. The registered enrollment target is 360 participants, below the 3,203-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (89% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05997875, a NA study of Chronic Kidney Disease and Hemodialysis Vascular Access, is actively recruiting participants, sponsored by University of Pennsylvania.

RECRUITING
Registry status
NA
Development phase
360 participants
Enrollment target
2
Study locations

Study Summary

The focus of this study is on vascular access for hemodialysis. This is a randomized clinical trial testing 3 educational approaches to help patients with advanced chronic kidney disease prepare for placement of hemodialysis vascular access. Study participants will each be assigned to one of the 3 approaches: 1) "Education", in which participants will be given a video and brochure that provide information about the types of vascular access and what can be expected before and after the vascular access is placed, 2) "Education-Plus", in which participants will be given the video and brochure and will also have sessions by telehealth with a motivational interviewing coach to provide additional support around vascular access placement, and 3) "Usual Care", in which participants will have the usual education provided by their kidney doctor and clinic staff just as if they were not in the study. Participants in all 3 groups will be asked to complete questionnaires by telephone and may be invited to be interviewed about their experience with the study intervention at the end of the study. Study participation will last for about 12 months, with most of the study activities taking place during the first 3 months.

Interventions

  • BEHAVIORAL Usual Care
  • BEHAVIORAL Motivational Interviewing
  • BEHAVIORAL Educational Materials
  • OTHER Patient Lists for Clinicians: System-Level Intervention

Study Locations (2)

North Carolina

  • University of North Carolina at Chapel Hill - Chapel Hill

Pennsylvania

  • University of Pennsylvania - Philadelphia

Trial Details

FieldValue
Enrollment Target 360 participants
Start Date 2023-12-05
Est. Completion 2027-09-30
Phase NA

Sponsor

University of Pennsylvania

1,423 total trials

What the Registry Record Tells You About NCT05997875

The ClinicalTrials.gov registry entry for NCT05997875 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 360 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,203-participant average among 101 other Chronic Kidney Disease trials with a reported enrollment target (89% lower). The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Kidney Disease appearing as the primary indexed condition, and to 4 interventions - of which Usual Care is the first listed.

NCT05997875 reports 2 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT05997875 about?

NCT05997875 is a clinical study titled "Transforming Hemodialysis-Related Vascular Access Education". The focus of this study is on vascular access for hemodialysis. This is a randomized clinical trial testing 3 educational approaches to help patients with advanced chronic kidney disease prepare for placement of hemodialysis vascular access. Study participants will each be assigned to one of the 3 a...

What is the current status of trial NCT05997875?

This trial is currently recruiting. It is a NA study. The enrollment target is 360 participants. The study started on 2023-12-05. Estimated completion is 2027-09-30.

What conditions does trial NCT05997875 study?

This clinical trial studies the following conditions: Chronic Kidney Disease, Hemodialysis Vascular Access.

What interventions are being tested in trial NCT05997875?

The interventions under investigation include: Usual Care (BEHAVIORAL), Motivational Interviewing (BEHAVIORAL), Educational Materials (BEHAVIORAL), Patient Lists for Clinicians: System-Level Intervention (OTHER).

Who is sponsoring clinical trial NCT05997875?

This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05997875 being conducted?

This trial has 2 study locations across North Carolina, Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Kidney Disease

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.